Lupus Trial, Recruiting NCT06308770 Sponsor: University of Edinburgh Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT06308770
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Systemic Lupus Erythematosus (SLE/Lupus).
  • You are 18 years old or older at the time of signing up.
  • You have been experiencing fatigue as an ongoing problem for at least the past 4 weeks, and it has a significant impact on your quality of life (rated 6 or higher on a scale of 1–10).
  • You are willing to give consent online, fill in questionnaires, and be randomly assigned to either standard care or a group programme through a secure online system.
  • You have not taken part in a group fatigue or pain management programme in the last 5 years.
  • You can read and hold a conversation in English confidently.
  • You have access to a computer, smartphone, or tablet with internet and audio/video capability.
  • You are able to, or willing to learn to, use an NHS-approved online platform.
  • You are willing to share a phone number, postal address, and email address for communication about the trial.

Who may not be able to join:

  • You do not understand English well enough to take part in a live online group session with other participants and facilitators who will likely only speak English.
  • You are unable to confirm your eligibility, complete online consent forms, or fill in questionnaires.
  • You are currently taking part in another interventional clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Helen Harris, BA MB BCh BAO, University of Edinburgh

Phone: 07762929927

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Edinburgh
Registry
ClinicalTrials.gov
Start date
8 April 2024
Est. completion
1 September 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Modified Fatigue Impact Score (MFIS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov